GLP-1 receptor agonists are increasingly used to manage type 2 diabetes and support weight management in the UK
And most importantly, your provider conducts routine follow-ups and lab monitoring to assess how your body is responding
doi: 10.1093/HUMREP/DEAE108.041 91 CestaCERotemRBatemanBTChodickGCohenJMFuruKet al
According to FDA prescribing information, approximately 20% of participants experience gastrointestinal side effects with either medication, while 60-75% of patients report at least one adverse event of any type
Potential Benefits of Microdosing GLP-1 RAs Reduced Side Effects: Lower doses minimize gastrointestinal discomfort, which can improve patient adherence and overall treatment tolerability
For patients in Connecticut who want to lose weight while protecting strength, energy, and lean muscle, Dr